<DOC>
	<DOCNO>NCT00971516</DOCNO>
	<brief_summary>The main goal study look way gum heal around dental implant place healthy patient compare patient type 2 diabetes . This study design answer follow question : - How much swelling occur around dental implant place patient type 2 diabetes ? - Is swell ( inflammation ) present absent initial heal phase placement dental implant ? - What differences amount swell ( inflammation ) patient without type 2 diabetes ? Are patient type 2 diabetes likely bone loss around dental implant ?</brief_summary>
	<brief_title>Healing Profile Titanium Dental Implants Placed Patients With Diabetes</brief_title>
	<detailed_description>Rationale : For evaluation/ monitoring dental implant , practitioner seem use simultaneously variety clinical , image-based laboratory measurement , probably fact measure likely provide important information regard complex series event dental implant site ( Guncu et al 2008 ) . Thus , propose study seek characterize first time , heal profile dental implant type 2 diabetic patient compare natural teeth , light microarray quantitative evaluation host response promote cytokine osteoclastogenesis-related factor level , correlate quantitative finding qualitative high-tech multi-modal clinical infra-red diagnosis data . This information may allow development new therapeutic intervention modality maximize protective minimize destructive aspect inflammation peri-implant tissue even early stage . If result preliminary study positive , longitudinal follow-up study conduct within population investigate relationship long-term period . Methods : A 1-year prospective pilot study perform 20 patient ( male ; 35-55 year old ) , 10 control type 2 diabetic ( HbA1c value &lt; 7.2 % ) 10 non diabetic match implant treatment indication serve control ( suffer partial edentulism ) . Patients receive least one dental implant ( Ankylos® , Dentsply , Germany ) . Patients attend Graduate Periodontics Clinic ( University Manitoba ) invite participate study . A comprehensive history take examination oral cavity carry patient implant evaluation . Based review history examination find one study personnel , potential subject identify satisfy follow inclusion exclusion criterion . Excluded study active periodontal disease , uncontrolled diabetes , smoker , metabolic bone diseases systemic disorder . All patient inform nature study volunteer sign informed consent form prior entry study . The patient receive least 1 one-stage Ankylos® implant ( Dentsply , Germany ) bone area . After restoration , patient follow 1 year . The heal profile determine quantitatively cytokines biomarkers peri-implant crevicular fluid ( PICF ) ( microarray ) qualitatively inflammatory infiltrate ( IR evaluation ) . Aims Approaches : Aim 1- To establish quantitatively qualitatively heal profile dental implant place type 2 diabetic patient . Aim 2- To compare level cytokine dental implant natural teeth . Approach : PICF/GCF sample collect diabetic non diabetic patient . The volume PICF/GCF determine ( Periotron 8000® ) subsequent cytokine assay ( Schierano et al 2008 ) . All sample evaluate simultaneously microarray technique ( Genepix® ) quantitative measurement concentration multiple cytokine : IL-1β , IL-2 , IL-4 , IL-6 , IL-8 , TNF-α , IFN-γ , IL-10 , IL-12p70 , IL-13 , TGF-β , IL-17 IL-23 , well OPG RANK-L ; qualitative measurement perform infra-red diagnosis . Aim 3- To determine initial bone stability dental implant place diabetic patient . Approach : Statistical analysis correlate data many time point regard cytokine level implant teeth ( PICF/GCF respectively ) patient ( diabetic non diabetic ) verify impact host response inflammation bone stability time .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Type 2 diabetes patient partial edentulism . Active periodontal disease , Uncontrolled diabetes , Smokers , Any metabolic bone diseases systemic disorder .</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>diabetes</keyword>
	<keyword>implant</keyword>
	<keyword>cytokine</keyword>
</DOC>